Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-09-10 Sale |
2024-09-13 5:10 pm |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO |
1,738 | $26.18 | $45,501 | 605,417 (Direct) |
View |
| 2024-09-03 Sale |
2024-09-05 4:08 pm |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
5,000 | $26.72 | $133,588 | 296,854 (Indirect Direct) |
View |
| 2024-09-03 Sale |
2024-09-05 4:05 pm |
Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer |
949 | $27.61 | $26,206 | 94,646 (Direct) |
View |
| 2024-08-26 Sale |
2024-08-29 4:30 pm |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
98,334 | $27.02 | $2,657,250 | 231,289 (Direct) |
View |
| 2024-08-23 Sale |
2024-08-28 11:11 am |
Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer |
14,051 | $27.52 | $386,714 | 120,459 (Direct) |
View |
| 2024-08-01 Sale |
2024-08-02 9:32 pm |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
5,000 | $26.75 | $133,756 | 301,854 (Indirect Direct) |
View |
| 2024-07-23 Sale |
2024-07-25 5:54 pm |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
161,855 | $27.07 | $4,381,867 | 323,431 (Direct) |
View |
| 2024-07-16 Sale |
2024-07-18 9:41 pm |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
34,811 | $28.04 | $976,274 | 236,317 (Direct) |
View |
| 2024-07-01 Sale |
2024-07-02 6:55 pm |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
5,000 | $23.4 | $117,020 | 306,854 (Indirect Direct) |
View |
| 2024-06-11 Sale |
2024-06-13 6:13 pm |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
2,516 | $22.64 | $56,965 | 310,790 (Indirect Direct) |
View |
| 2024-06-11 Sale |
2024-06-13 6:11 pm |
Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer |
2,825 | $22.64 | $63,961 | 74,867 (Direct) |
View |
| 2024-06-11 Sale |
2024-06-13 6:09 pm |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
2,831 | $22.64 | $64,094 | 46,799 (Direct) |
View |
| 2024-06-11 Sale |
2024-06-13 6:06 pm |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
2,380 | $22.64 | $53,886 | 180,178 (Direct) |
View |
| 2024-06-11 Sale |
2024-06-13 6:04 pm |
Akero Therapeutics Inc. | AKRO | Lamy Patrick Senior VP, Commercial Strategy |
569 | $22.64 | $12,883 | 18,562 (Direct) |
View |
| 2024-06-11 Sale |
2024-06-13 6:01 pm |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO |
7,894 | $22.64 | $178,728 | 581,553 (Direct) |
View |
| 2024-06-03 Sale |
2024-06-05 5:05 pm |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
5,000 | $19.29 | $96,440 | 313,306 (Indirect Direct) |
View |
| 2024-05-01 Sale |
2024-05-02 9:07 pm |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
5,000 | $20.15 | $100,750 | 318,306 (Indirect Direct) |
View |
| 2024-04-01 Sale |
2024-04-03 6:55 pm |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
5,000 | $24.38 | $121,913 | 323,306 (Indirect Direct) |
View |
| 2024-03-13 Sale |
2024-03-15 4:45 pm |
Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer |
723 | $28.33 | $20,483 | 77,692 (Direct) |
View |
| 2024-03-13 Sale |
2024-03-15 4:44 pm |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
724 | $28.33 | $20,511 | 49,630 (Direct) |
View |
| 2024-03-13 Sale |
2024-03-15 4:43 pm |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO |
1,969 | $28.33 | $55,782 | 589,447 (Direct) |
View |
| 2024-03-13 Sale |
2024-03-15 4:42 pm |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
651 | $28.33 | $18,443 | 328,306 (Indirect Direct) |
View |
| 2024-03-13 Sale |
2024-03-15 4:42 pm |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
619 | $28.33 | $17,536 | 182,558 (Direct) |
View |
| 2024-03-04 Sale |
2024-03-06 8:14 pm |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO |
75,000 | $32.87 | $2,465,063 | 845,811 (Direct) |
View |
| 2024-03-04 Sale |
2024-03-06 8:13 pm |
Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer |
20,646 | $35.49 | $732,727 | 167,941 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-09-03 Exercise |
2024-09-05 4:05 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer |
949 | $0.615 | 94,646 (Direct) |
View |
| 2024-09-03 Exercise |
2024-09-05 4:05 pm |
N/A 2028-09-26 |
Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer |
949 | $0 | 94,646 (Direct) |
View |
| 2024-08-26 Exercise |
2024-08-29 4:30 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
41,291 | $21.09 | 231,289 (Direct) |
View |
| 2024-08-26 Exercise |
2024-08-29 4:30 pm |
N/A 2029-04-04 |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
98,334 | $0 | 231,289 (Direct) |
View |
| 2024-08-26 Exercise |
2024-08-29 4:30 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
32,671 | $7.009 | 231,289 (Direct) |
View |
| 2024-08-26 Exercise |
2024-08-29 4:30 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
24,372 | $19.87 | 231,289 (Direct) |
View |
| 2024-08-23 Exercise |
2024-08-28 11:11 am |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer |
14,051 | $0.615 | 120,459 (Direct) |
View |
| 2024-08-23 Exercise |
2024-08-28 11:11 am |
N/A 2028-09-26 |
Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer |
14,051 | $0 | 120,459 (Direct) |
View |
| 2024-08-16 Exercise |
2024-08-20 11:45 am |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO |
24,538 | $0.615 | 607,155 (Direct) |
View |
| 2024-08-16 Exercise |
2024-08-20 11:45 am |
N/A 2028-10-17 |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO |
24,538 | $0 | 607,155 (Direct) |
View |
| 2024-07-23 Exercise |
2024-07-25 5:54 pm |
N/A 2029-04-04 |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
161,855 | $0 | 323,431 (Direct) |
View |
| 2024-07-23 Exercise |
2024-07-25 5:54 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
161,855 | $7.009 | 323,431 (Direct) |
View |
| 2024-07-16 Exercise |
2024-07-18 9:41 pm |
N/A 2029-04-04 |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
29,803 | $0 | 236,317 (Direct) |
View |
| 2024-07-16 Exercise |
2024-07-18 9:41 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
29,803 | $7.009 | 236,317 (Direct) |
View |
| 2024-06-28 Option Award |
2024-07-02 6:57 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
1,064 | $19.94 | 181,242 (Direct) |
View |
| 2024-06-28 Option Award |
2024-07-02 6:56 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer |
1,064 | $19.94 | 75,931 (Direct) |
View |
| 2024-06-28 Option Award |
2024-07-02 6:56 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Lamy Patrick Senior VP, Commercial Strategy |
221 | $19.94 | 18,783 (Direct) |
View |
| 2024-06-28 Option Award |
2024-07-02 6:55 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO |
1,064 | $19.94 | 582,617 (Direct) |
View |
| 2024-06-28 Option Award |
2024-07-02 6:55 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
1,064 | $19.94 | 306,854 (Direct) |
View |
| 2024-06-08 Option Award |
2024-06-11 5:31 pm |
N/A 2034-06-07 |
Akero Therapeutics Inc. | AKRO | Xu Yuan Director |
26,000 | $0 | 26,000 (Direct) |
View |
| 2024-06-08 Option Award |
2024-06-11 5:29 pm |
N/A 2034-06-07 |
Akero Therapeutics Inc. | AKRO | Graham G. Walmsley Director |
26,000 | $0 | 26,000 (Direct) |
View |
| 2024-06-08 Option Award |
2024-06-11 5:28 pm |
N/A 2034-06-07 |
Akero Therapeutics Inc. | AKRO | Iwicki Mark T Director |
26,000 | $0 | 26,000 (Direct) |
View |
| 2024-06-08 Option Award |
2024-06-11 5:25 pm |
N/A 2034-06-07 |
Akero Therapeutics Inc. | AKRO | Heyman Tomas J. Director |
26,000 | $0 | 26,000 (Direct) |
View |
| 2024-06-08 Option Award |
2024-06-11 5:24 pm |
N/A 2034-06-07 |
Akero Therapeutics Inc. | AKRO | Henderson Jane Director |
26,000 | $0 | 26,000 (Direct) |
View |
| 2024-06-08 Option Award |
2024-06-11 5:22 pm |
N/A 2034-06-07 |
Akero Therapeutics Inc. | AKRO | Harrison Seth Loring Director |
26,000 | $0 | 26,000 (Direct) |
View |
| 2024-06-08 Option Award |
2024-06-11 5:20 pm |
N/A 2034-06-07 |
Akero Therapeutics Inc. | AKRO | Judy Chou Director |
26,000 | $0 | 26,000 (Direct) |
View |
| 2024-04-29 Option Award |
2024-05-01 7:36 pm |
N/A 2034-04-28 |
Akero Therapeutics Inc. | AKRO | Gangloff Scott A. Chief Technology Officer |
225,000 | $0 | 225,000 (Direct) |
View |
| 2024-03-04 Exercise |
2024-03-06 8:14 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO |
57,733 | $16 | 845,811 (Direct) |
View |
| 2024-03-04 Exercise |
2024-03-06 8:14 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO |
17,267 | $21.1 | 845,811 (Direct) |
View |
| 2024-03-04 Exercise |
2024-03-06 8:14 pm |
N/A 2029-06-18 |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO |
75,000 | $0 | 845,811 (Direct) |
View |
| 2024-03-04 Exercise |
2024-03-06 8:13 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer |
10,646 | $21.09 | 167,941 (Direct) |
View |
| 2024-03-04 Exercise |
2024-03-06 8:13 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer |
10,000 | $6.36 | 167,941 (Direct) |
View |
| 2024-03-04 Exercise |
2024-03-06 8:13 pm |
N/A 2029-01-15 |
Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer |
20,646 | $0 | 167,941 (Direct) |
View |
| 2024-03-01 Exercise |
2024-03-05 5:16 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
83,321 | $0.615 | 328,957 (Direct) |
View |
| 2024-03-01 Exercise |
2024-03-05 5:16 pm |
N/A 2028-10-17 |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
83,321 | $0 | 328,957 (Direct) |
View |